Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management
Open Access
Abstract
Mitochondrial cardiomyopathy (MCM) is characterized by abnormal heart-muscle structure and function, caused by mutations in the nuclear genome or mitochondrial DNA. The heterogeneity of gene mutations and various clinical presentations in patients with cardiomyopathy make its diagnosis, molecular mechanism, and therapeutics great challenges. This review describes the molecular epidemiology of MCM and its clinical features, reviews the promising diagnostic tests applied for mitochondrial diseases and cardiomyopathies, and details the animal and cellular models used for modeling cardiomyopathy and to investigate disease pathogenesis in a controlled in vitro environment. It also discusses the emerging therapeutics tested in pre-clinical and clinical studies of cardiac regeneration.Keywords
Funding Information
- Start-up Grant for Stem Cell Regenerative Medicine (5001-4001010, JCYJ20210324114606019)
- Shenzhen Science and Technology Program (5001-4001010, JCYJ20210324114606019)
This publication has 99 references indexed in Scilit:
- Cardiomyocyte Specific Deletion of Crif1 Causes Mitochondrial Cardiomyopathy in MicePLOS ONE, 2013
- Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxiaDisease Models & Mechanisms, 2013
- Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and managementEuropean Heart Journal, 2012
- Erosion of Dosage Compensation Impacts Human iPSC Disease ModelingCell Stem Cell, 2012
- Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathyProceedings of the National Academy of Sciences, 2012
- Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic dietProceedings of the National Academy of Sciences, 2011
- Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondriaNucleic Acids Research, 2011
- Adenine Nucleotide Translocase 1 Deficiency Results in Dilated Cardiomyopathy With Defects in Myocardial Mechanics, Histopathological Alterations, and Activation of ApoptosisJACC: Cardiovascular Imaging, 2011
- Therapeutic Targeting of Mitochondrial Superoxide in HypertensionCirculation Research, 2010
- Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failureJournal of Molecular and Cellular Cardiology, 2007